News Search

Osborne Clarke advises Logical Clocks on its €5.0m Series A investment round

The Osborne Clarke team in Sweden has advised Logical Clocks on its €5.0m Series A equity financing round led by...

Published on 19/07/2021

Read time 1m

Osborne Clarke and Withers in the sale of Things Mobile to Wireless Logic

Osborne Clarke, with a team led by partner Alessandro Villa assisted by Alberto Passera and Matteo Tracanella advised the UK...

Published on 15/07/2021

Read time 1m

Osborne Clarke advises BGF and CPT Capital on £11M equity fundraising round

International legal practice Osborne Clarke has advised BGF and CPT Capital on a £11million equity fundraising round for THIS, a...

Published on 13/07/2021

Read time 1m

Osborne Clarke advises Element Ventures on its investment in Coincover as part of a $9M Series A fundraising

International legal practice Osborne Clarke has advised Element Ventures, a global venture capital fund, as the lead investor in Coincover's...

Published on 13/07/2021

Read time 3m

Osborne Clarke advises NeRRe Therapeutics on its £20 million Series B2 financing round

International law firm Osborne Clarke has advised NeRRe Therapeutics on its £20 million Series B2 financing round. The financing involved...

Published on 12/07/2021

Read time 1m

Osborne Clarke in Centauria's arrangement with creditors

Osborne Clarke, with a team composed of partner Filippo Canepa and senior associate Barbara Schiavo advised Centauria, a publishing company...

Published on 09/07/2021

Belgium

China

France

Germany

India

Italy

Poland

Singapore

Spain

Sweden

The Netherlands

UK

USA

Belgium

China

France

Germany

India

Italy

Poland

Singapore

Spain

Sweden

The Netherlands

UK

USA

Osborne Clarke advises Logical Clocks on its €5.0m Series A investment round

Osborne Clarke and Withers in the sale of Things Mobile to Wireless Logic

Osborne Clarke advises BGF and CPT Capital on £11M equity fundraising round

Osborne Clarke advises Element Ventures on its investment in Coincover as part of a $9M Series A fundraising

Osborne Clarke advises NeRRe Therapeutics on its £20 million Series B2 financing round

Osborne Clarke in Centauria's arrangement with creditors

Sign up for our newsletter

Legal Notice